Nuwellis Inc. (NUWE)
NASDAQ: NUWE
· Real-Time Price · USD
6.33
0.79 (14.26%)
At close: Aug 18, 2025, 3:59 PM
6.17
-2.53%
Pre-market: Aug 19, 2025, 08:00 AM EDT
14.26% (1D)
| Bid | 6.16 |
| Market Cap | 720.52K |
| Revenue (ttm) | 8.79M |
| Net Income (ttm) | -9.85M |
| EPS (ttm) | 630.42 |
| PE Ratio (ttm) | 0.01 |
| Forward PE | -0.13 |
| Analyst | Buy |
| Ask | 6.28 |
| Volume | 1,165,031 |
| Avg. Volume (20D) | 1,029,902 |
| Open | 5.67 |
| Previous Close | 5.54 |
| Day's Range | 5.60 - 6.72 |
| 52-Week Range | 4.82 - 175.98 |
| Beta | -0.01 |
About NUWE
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NUWE
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for NUWE stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsEarnings Surprise
Nuwellis has released their quartely earnings
on Aug 14, 2025:
1 month ago
-1.19%
NUWE stock has given up its prior loss. Nuwellis s...
Unlock content with
Pro Subscription
1 month ago
-1.19%
Nuwellis shares are trading lower after the company announced it has terminated its REVERSE-HF clinical trial to prioritize resources and redirect investment.
